[1] |
FISHBEIN A B, SILVERBERG J I, WILSON E J, et al. Update on atopic dermatitis:Diagnosis,severity assessment,and treatment selection[J]. J Allergy Clin Immunol Pract, 2020, 8(1):91-101. doi:10.1016/j.jaip.2019.06.044.
|
[2] |
ELSNER P, AGNER T. Hand eczema:treatment[J]. J Eur Acad Dermatol Venereol, 2020, 34(Suppl 1):13-21. doi:10.1111/jdv.16062.
|
[3] |
COHEN J N, BOWMAN S, LASZIK Z G, et al. Clinicopathologic overlap of psoriasis,eczema,and psoriasiform dermatoses:a retrospective study of T helper type 2 and 17 subsets,interleukin 36,and β-defensin 2 in spongiotic psoriasiform dermatitis,sebopsoriasis,and tumor necrosis factor α inhibitor-associated dermatitis[J]. J Am Acad Dermatol, 2020, 82(2):430-439. doi:10.1016/j.jaad.2019.08.023.
|
[4] |
申春平, 闫琦, 王召阳, 等. 低龄婴儿湿疹的流行病学调查与治疗随访[J]. 临床皮肤科杂志, 2015, 44(8):469-472.
|
|
SHEN C P, YAN Q, WANG Z Y, et al. Epidemiologic investigation and treatm ent for the younger infantile eczema[J]. J Clin Dermato, 2015, 44(8):469-472. doi:10.16761/j.cnki.1000-4963.2015.08.017.
|
[5] |
HE H, GUTTMAN-YASSKY E. JAK inhibitors for atopic dermatitis:an update[J]. Am J Clin Dermatol, 2019, 20(2):181-192. doi:10.1007/s40257-018-0413-2.
|
[6] |
WYNN T A. Type 2 cytokines: mechanisms and therapeutic strategies[J]. Nat Rev Immunol, 2015, 15(5):271-282. doi:10.1038/nri3831.
|
[7] |
杨薇, 钟波. IL-36细胞因子在炎性疾病与肿瘤中的作用机制[J]. 中国细胞生物学学报, 2022, 44(4):737-746.
|
|
YANG W, ZHONG B. The roles of IL-36 cytokines in inflammatory diseases and cancers[J]. Chinese Journal of Cell Biology, 2022, 44(4):737-746. doi:10.11844/cjcb.2022.04.0020.
|
[8] |
LEON G, HERNANDEZ SANTANA Y E, IRWIN N, et al. IL-36 cytokines imprint a colitogenic phenotype on CD4+ T helper cells[J]. Mucosal Immunol, 2022, 15(3):491-503. doi:10.1038/s41385-022-00488-w.
|
[9] |
肖夏夏, 韩春芳, 于海英, 等. IL-36在哮喘患儿血清中的水平及临床意义[J]. 潍坊医学院学报, 2022, 44(1):64-67.
|
|
XIAO X X, HAN C F, YU H Y, et al. The levels and clinical significance of serum IL-36 in children with bronchial asthma[J]. Acta Acad Med Weifang, 2022, 44(1):64-67. doi:10.16846/j.issn.1004-3101.2022.01.020.
|
[10] |
OTOBE S, SUGAYA M, NAKAJIMA R, et al. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome[J]. J Dermatol, 2018, 45(4):468-471. doi:10.1111/1346-8138.14198.
|
[11] |
FU Y, LOU H, WANG C, et al. T cell subsets in cord blood are influenced by maternal allergy and associated with atopic dermatitis[J]. Pediatr Allergy Immunol, 2013, 24(2):178-186. doi:10.1111/pai.12050.
|
[12] |
赵辨. 湿疹面积及严重度指数评分法[J]. 中华皮肤科杂志, 2004, 37(1):3-4.
|
|
ZHAO B. Eczema area and severity index[J]. Chin J Dermatol, 2004, 37(1):3-4. doi:10.16846/j.issn.1004-3101.2022.01.020.
|
[13] |
ABUABARA K, YU A M, OKHOVAT J P, et al. The prevalence of atopic dermatitis beyond childhood:A systematic review and meta-analysis of longitudinal studies[J]. Allergy, 2018, 73(3):696-704. doi:10.1111/all.13320.
|
[14] |
张锦姮, 汤华, 孙琦, 等. 沈阳市某区儿童湿疹发生情况及影响因素分析[J]. 中国学校卫生, 2020, 41(3):416-419.
|
|
ZHANG J H, TANG H, SUN Q, et al. Prevalence and influencing factors of eczema among children in a district of Shenyang[J]. Chin J Sch Health, 2020, 41(3):416-419. doi:10.16835/j.cnki.1000-9817.2020.03.026.
|
[15] |
YANG L, FU J, ZHOU Y. Research progress in atopic march[J]. Front Immunol, 2020, 11:1907. doi:10.3389/fimmu.2020.01907.
|
[16] |
KELLEHER M M, CRO S, CORNELIUS V, et al. Skin care interventions in infants for preventing eczema and food allergy[J]. Cochrane Database Syst Rev, 2021, 2(2):CD013534. doi:10.1002/14651858.CD013534.pub2.
|
[17] |
TSANG M S, SUN X, WONG C K. The role of new IL-1 family members (IL-36 and IL-38)in atopic dermatitis,allergic asthma,and allergic rhinitis[J]. Curr Allergy Asthma Rep, 2020, 20(8):40. doi:10.1007/s11882-020-00937-1.
|
[18] |
叶佩琪, 吴维佳, 万年青, 等. 孕期食物摄入与婴儿湿疹关联的队列研究[J]. 中华疾病控制杂志, 2019, 23(10):1213-1218.
|
|
YE P Q, WU W J, WAN N Q, et al. The effect of maternal food consumption during pregnancy on infantile eczema:a cohort study[J]. Chinese Journal of Disease Control & Prevention, 2019, 23(10):1213-1218.
|
[19] |
李敏敏, 陆春燕, 王晓明. 脐血25羟基维生素D3对早期婴儿特应性皮炎的预测作用[J]. 中国当代儿科杂志, 2018, 20(4):303-307.
|
|
LI M M, LU C Y, WANG X M. Predictive value of cord blood 25(OH)D3 for early infantile atopic dermatitis[J]. Chin J Contemp Pediatr, 2018, 20(4):303-307. doi:10.7499/j.issn.1008-8830.2018.04.010.
|
[20] |
CRNKOVIĆ H T, BENDELJA K, ŠIMIĆ KLARIĆ A, et al. Family history and cord blood eosinophil count as predictors for atopic manifestations[J]. Cent Eur J Public Health, 2019, 27(4):267-271. doi:10.21101/cejph.a5601.
|
[21] |
MAHIL S K, CATAPANO M, DI MEGLIO P, et al. An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target[J]. Sci Transl Med, 2017, 9(411):eaan2514. doi:10.1126/scitranslmed.aan2514.
|
[22] |
VIGNE S, PALMER G, LAMACCHIA C, et al. IL-36R ligands are potent regulators of dendritic and T cells[J]. Blood, 2011, 118(22):5813-5823. doi:10.1182/blood-2011-05-356873.
|
[23] |
MAI S Z, LI C J, XIE X Y, et al. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus:association with disease activity and arthritis[J]. Int Immunopharmacol, 2018, 58:103-108. doi:10.1016/j.intimp.2018.03.011.
|
[24] |
TSOI L C, RODRIGUEZ E, STÖLZL D, et al. Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses[J]. J Allergy Clin Immunol, 2020, 145(5):1406-1415. doi:10.1016/j.jaci.2019.11.047.
|
[25] |
LIU H, ARCHER N K, DILLEN C A, et al. Staphylococcus aureus epicutaneous exposure drives skin inflammation via IL-36-mediated T cell responses[J]. Cell Host Microbe, 2017, 22(5):653-666.e5. doi:10.1016/j.chom.2017.10.006.
|
[26] |
GAMEZ C, METCALFE J, PRESCOTT S L, et al. Lower cord blood IL-17 and IL-25,but not other epithelial cell-derived cytokines are associated with atopic dermatitis in infancy[J]. Int Arch Allergy Immunol, 2021, 182(6):474-478. doi:10.1159/000512919.
|
[27] |
BRUNNER P M. Early immunologic changes during the onset of atopic dermatitis[J]. Ann Allergy Asthma Immunol, 2019, 123(2):152-157. doi:10.1016/j.anai.2019.03.033.
|
[28] |
PATRICK G J, LIU H, ALPHONSE M P, et al. Epicutaneous Staphylococcus aureus induces IL-36 to enhance IgE production and ensuing allergic disease[J]. J Clin Invest, 2021, 131(5):e143334. doi:10.1172/JCI143334.
|
[29] |
BEREKMÉRI A, LATZKO A, ALASE A, et al. Detection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema[J]. J Allergy Clin Immunol, 2018, 142(3):988-991.e4. doi:10.1016/j.jaci.2018.04.031.
|
[30] |
SUÁREZ-FARIÑAS M, UNGAR B, CORREA DA ROSA J, et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications[J]. J Allergy Clin Immunol, 2015, 135(5):1218-1227. doi:10.1016/j.jaci.2015.03.003.
|
[31] |
GEOGHEGAN J A, IRVINE A F, FOSTER T J. Staphylococcus aureus and atopic dermatitis:A complex and evolving relationship[J]. Trends Microbiol, 2018, 26(6):484-497. doi:10.1016/j.tim.2017.11.008.
|
[32] |
CHEN C H, LEE Y L, WU M H, et al. Sex-moderated interactions between IL4/IL13 pathway genes and prenatal environment on cord blood IgE levels[J]. Clin Exp Allergy, 2019, 49(8):1128-1138. doi:10.1111/cea.13419.
|